Michael Riley - SPDR SP Vice President
| XBI Etf | USD 128.85 1.50 1.18% |
Michael P. Riley is Principle, State Street Global Advisors Assistant Vice President, State Street Bank and Trust Company .
| Age | 43 |
| Tenure | 21 years |
| Issuer | SSgA |
| Inception Date | 2006-01-31 |
| Benchmark | S&P Biotechnology Select Industry Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 8.23 Billion |
| Average Trading Volume | 9.96 Million |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
Similar Fund Executives
| Found 4 records | One Year Return | ||
| Ira Shapiro | iShares MSCI Brazil | 51 | |
| Amy Schioldager | iShares MSCI Brazil | 55 | |
| Matt Tucker | iShares MSCI Brazil | N/A | |
| Michael Latham | iShares MSCI Brazil | 51 | |
SPDR SP Biotech Money Managers
| Gary French, Treasurer | ||
| John Clark, Assistant Treasurer | ||
| Dave Kelly, Independent Trustee | ||
| Helen Peters, Independent Trustee | ||
| Matthew Flaherty, Assistant Treasurer | ||
| Michael Riley, Vice President | ||
| Mary Zeven, Secretary | ||
| Chad Hallett, Assistant Treasurer of Street tracks series trust | ||
| Scott Zoltowski, Assistant Secretary | ||
| Peter Ambrosini, Chief Compliance Officer | ||
| James Ross, President Trustee | ||
| Frank Nesvet, Independent Trustee |
SPDR Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is SPDR SP a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 19.71 X | |||
| Price To Book | 2.64 X | |||
| Price To Sales | 7.52 X | |||
| Number Of Employees | 12 | |||
| Beta | 1.46 | |||
| Total Asset | 7.34 B | |||
| One Year Return | 38.20 % | |||
| Three Year Return | 13.80 % | |||
| Five Year Return | (3.30) % | |||
| Ten Year Return | 8.90 % |
Currently Active Assets on Macroaxis
When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
SPDR SP Biotech's market price often diverges from its book value, the accounting figure shown on SPDR's balance sheet. Smart investors calculate SPDR SP's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since SPDR SP's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.